Abstract
We assessed the role played by the ERAP1 gene in Turkish patients with ankylosing spondylitis (AS) in terms of disease susceptibility, clinical manifestations, and disease severity. We included 150 consecutive AS patients who met the modified New York classification criteria and 150 healthy controls. We documented the presence of 10 ERAP1 single-nucleotide polymorphisms (SNPs) and HLA-B27 in these patients. ERAP1 SNPs were genotyped using competitive allele-specific polymerase chain reaction. Differences between genotype and allele frequencies were compared using the Pearson’s Chi-square test. The associations between ERAP1 SNPs, on the one hand, and with disease severity and clinical findings, on the other, were determined. One SNP, rs26653, was significantly associated with AS susceptibility (OR 1.609, 95 % CI 1.163–2.226; p = 0.004). The population-attributable risk of possession of the rs26653 SNP allele was 23.4 %. No relationship was noted between HLA-B27 positivity and the distribution of rs26653 genotype frequency. No associations were seen between disease severity measures and clinical manifestations of AS. In summary, an ERAP1 polymorphism was associated with AS in a Turkish population. The contributions of HLA-B27 and the rs26653 SNP to AS pathogenesis appear to be independent.
Similar content being viewed by others
References
Thomas GP, Brown MA (2010) Genetics and genomics of ankylosing spondylitis. Immunol Rev 233:162–180
Brown MA (2009) Genetics and the pathogenesis of ankylosing spondylitis. Curr Opin Rheumatol 21:318–323
Reveille JD (2006) The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 18:332–341
Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R (2006) The genetics of spondyloarthropathies. Jt Bone Spine 73:355–362
Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P (1997) Susceptibility to ankylosing spondylitis in twins: susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40:1823–1828
Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Harris JR, Junker P (2008) Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 37:120–126
Khan MA, Mathieu A, Sorrentino R, Akkoc N (2007) The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 6:183–189
van der Linden S, Valkenburg H, Cats A (1983) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol 22:18–19
Reveille JD, Sims AM, Danoy P et al (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127
Burton PR, Clayton DG, Cardon LR et al (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329–1337
Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P (2009) Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 60:1317–1323
Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, Cai Q, Sun L, Duncan E, Wang N, Yu Q, Xu A, Fu Y, Brown MA, Xu H (2009) Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 60:3263–3268
Choi CB, Kim TH, Jun JB, Lee HS, Shim SC, Lee B, Pope A, Uddin M, Rahman P, Inman RD (2010) ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann Rheum Dis 69:582–584
Pimentel-Santos FM, Ligeiro D, Matos M, Mourao AF, Sousa E, Pinto P, Ribeiro A, Sousa M, Barcelos A, Godinho F, Cruz M, Fonseca JE, Guedes-Pinto H, Trindade H, Evans DM, Brown MA, Branco JC (2009) Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 27:800–806
Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, Appleton LH, Sturrock RD, Stone MA, Oppermann U, Brown MA, Wordsworth BP (2009) Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 18:4204–4212
Pazar B, Safrany E, Gergely P, Szanto S, Szekanecz Z, Poor G (2010) Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 37:379–384
Chen R, Yao L, Meng T, Xu W (2012) The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls. Rheumatol Int 32:909–914
Szczypiorska M, Sanchez A, Bartolome N, Arteta D, Sanz J, Brito E, Fernandez P, Collantes E, Martinez A, Tejedor D, Artieda M, Mulero J (2011) ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford) 50:1969–1975
Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, Wordsworth BP, Cornelis F (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55:268–270
Liu Y, Jiang L, Cai Q, Danoy P, Barnardo MC, Brown MA, Xu H (2010) Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens 75:61–64
Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60:93–102
Li C, Lin Z, Xie Y, Guo Z, Huang J, Wei Q, Li QX, Wang X, Cao S, Liao Z, Xu M, Shen Y, Gu J (2011) ERAP1 is associated with ankylosing spondylitis in Han Chinese. J Rheumatol 38:317–321
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698
Tsui FW, Haroon N, Reveille JD, Rahman P, Chiu B, Tsui HW, Inman RD (2010) Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 69:733–736
Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagh KL, Brown MA, Bowness P, Wordsworth P, Kessler BM, Oppermann U (2011) Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 108:7745–7750
Goto Y, Hattori A, Ishii Y, Tsujimoto M (2006) Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 580:1833–1838
Haroon N, Tsui FW, Chiu B, Tsui HW, Inman RD (2010) Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J Rheumatol 37:1907–1910
Mehta AM, Jordanova ES, Corver WE, van Wezel T, Uh HW, Kenter GG, Jan Fleuren G (2009) Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes Chromosomes Cancer 48:410–418
Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M, Konice M, Aral O, Ocal L (2008) Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Jt Bone Spine 75:299–302
Wang CM, Ho HH, Chang SW, Wu YJ, Lin JC, Chang PY, Wu J, Chen JY (2012) ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthr Res Ther 14:R125
Evans DM, Spencer CC, Pointon JJ et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43:761–767
Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD (2012) Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis 71:589–595
Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, Brown MA (2001) Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 44:1396–1400
Brophy S, Hickey S, Menon A, Taylor G, Bradbury L, Hamersma J, Calin A (2004) Concordance of disease severity among family members with ankylosing spondylitis? J Rheumatol 31:1775–1778
Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665–670
Chavan H, Samant R, Deshpande A, Mankeshwar R (2011) Correlation of HLA B27 subtypes with clinical features of ankylosing spondylitis. Int J Rheum Dis 14:369–374
Munoz-Fernandez S, Martin-Mola E (2006) Uveitis. Best Pract Res Clin Rheumatol 20:487–505
Ehrenfeld M (2012) Spondyloarthropathies. Best Pract Res Clin Rheumatol 26:135–145
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66
Wu Z, Lin Z, Wei Q, Gu J (2009) Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism. Rheumatol Int 29:389–392
Acknowledgments
We wish to thank the patients and controls for providing blood samples, and our colleagues Associate Professor Umut Kalyoncu and MD Ulas Yakut for their assistance. This work was supported by Turkish Society of Rheumatology (Project AD-2011/99).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cinar, M., Akar, H., Yilmaz, S. et al. A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population. Rheumatol Int 33, 2851–2858 (2013). https://doi.org/10.1007/s00296-013-2824-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2824-y